Ameritas Advisory Services’s iShares Biotechnology ETF IBB Stock Holding History

Ameritas Advisory Services’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$969K	Buy	5,096 +1,268	+33%	+$218K	0.02%	569
2026 Q1	$646K	Sell	3,828 -96	-2%	-$16.4K	0.03%	498
2025 Q4	$662K	Buy	3,924 +3,179	+427%	+$516K	0.02%	470
2025 Q3	$107K	Sell	745 -4,142	-85%	-$565K	0.01%	810
2025 Q2	$618K	Sell	4,887 -25,989	-84%	-$3.19M	0.03%	454
2025 Q1	$3.96M	Buy	30,876 +1,782	+6%	+$242K	0.16%	142
2024 Q4	$3.85M	Buy	29,094 +2,508	+9%	+$353K	0.13%	151
2024 Q3	$3.87M	Sell	26,586 -2,334	-8%	-$338K	0.17%	131
2024 Q2	$3.97M	Buy	28,920 +5,940	+26%	+$793K	0.15%	140
2024 Q1	$3.1M	Buy	22,980 +13,269	+137%	+$1.81M	0.13%	173
2023 Q4	$1.32M	Sell	9,711 -3,874	-29%	-$473K	0.07%	234
2023 Q3	$1.64M	Buy	13,585 +3,840	+39%	+$488K	0.08%	233
2023 Q2	$1.21M	Sell	9,745 -1,721	-15%	-$224K	0.16%	151
2023 Q1	$1.5M	Sell	11,466 -2,134	-16%	-$279K	0.08%	244
2022 Q4	$1.79M	Buy	13,600 +2,336	+21%	+$302K	0.08%	238
2022 Q3	$1.32M	Buy	11,264 +2,442	+28%	+$303K	0.08%	237
2022 Q2	$1.04M	Sell	8,822 -650	-7%	-$77.2K	0.06%	281
2022 Q1	$1.23M	Buy	9,472 +483	+5%	+$62.9K	0.05%	293
2021 Q4	$1.37M	Buy	+8,989	New	+$1.39M	0.05%	279

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Ameritas Advisory Services's IBB Position: Q2 2026 in Review

Ameritas Advisory Services increased its iShares Biotechnology ETF (IBB) stake by 33% in Q2 2026, buying an estimated $218K and bringing the position to 5,096 shares worth $969K. The position accounts for 0.02% of the portfolio, ranked #569.

Ameritas Advisory Services first reported a position in IBB in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.97M in Q2 2024. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Ameritas Advisory Services held 5,096 shares of iShares Biotechnology ETF worth $969K as of Q2 2026.
Ameritas Advisory Services bought 1,268 iShares Biotechnology ETF shares in Q2 2026, an estimated $218K.
iShares Biotechnology ETF made up 0.02% of Ameritas Advisory Services's portfolio in Q2 2026, its #569 holding.
Ameritas Advisory Services first reported a position in iShares Biotechnology ETF in Q4 2021 and has held it in 19 quarters since.
Ameritas Advisory Services's iShares Biotechnology ETF position peaked at $3.97M in Q2 2024.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Ameritas Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.